Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Solari

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Thorax|March 7, 2013
Another chemokine target bites the dust?Roberto Solari
European Journal of Pharmacology|May 19, 2015
Targeting chemokine receptors in disease--a case study of CCR4Roberto Solari, James E Pease
Expert Opinion on Drug Discovery|November 12, 2013
High-throughput screening and structure-based approaches to hit discovery: is there a clear winner?Harren Jhoti, Stephen Rees, Roberto Solari
European Journal of Pharmacology|July 13, 2014
"Chemokine receptors as therapeutic targets: Why aren't there more drugs?"Roberto Solari, James E Pease, Malcolm Begg
Expert Opinion on Drug Discovery|June 5, 2012
The importance of chronobiology to drug discoveryStuart N Farrow, Roberto Solari, Timothy M Willson
Drug Discovery Today|July 5, 2011
Animal models of asthma: value, limitations and opportunities for alternative approachesAnthony M Holmes, Roberto Solari, Stephen T Holgate
Journal of Leukocyte Biology|December 25, 2015
Biased agonism at chemokine receptors: obstacles or opportunities for drug discovery?Caroline A Anderson, Roberto Solari, James E Pease
Expert Opinion on Drug Discovery|March 26, 2019
Are academic drug discovery efforts receiving more recognition with declining industry efficiency?Justin S Bryans, Catherine A Kettleborough, Roberto Solari
Current Opinion in Chemical Biology|May 29, 2013
Correctors of the basic trafficking defect of the mutant F508del-CFTR that causes cystic fibrosisVéronique Birault, Roberto Solari, John Hanrahan, et al.
Expert Opinion on Drug Discovery|March 20, 2013
Academia-industry partnerships in drug discoveryMichael Dalrymple, Debbie Taylor, Catherine Kettleborough, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Thorax|March 7, 2013
Another chemokine target bites the dust?Roberto Solari
European Journal of Pharmacology|May 19, 2015
Targeting chemokine receptors in disease--a case study of CCR4Roberto Solari, James E Pease
Expert Opinion on Drug Discovery|November 12, 2013
High-throughput screening and structure-based approaches to hit discovery: is there a clear winner?Harren Jhoti, Stephen Rees, Roberto Solari
European Journal of Pharmacology|July 13, 2014
"Chemokine receptors as therapeutic targets: Why aren't there more drugs?"Roberto Solari, James E Pease, Malcolm Begg
Expert Opinion on Drug Discovery|June 5, 2012
The importance of chronobiology to drug discoveryStuart N Farrow, Roberto Solari, Timothy M Willson
Drug Discovery Today|July 5, 2011
Animal models of asthma: value, limitations and opportunities for alternative approachesAnthony M Holmes, Roberto Solari, Stephen T Holgate
Journal of Leukocyte Biology|December 25, 2015
Biased agonism at chemokine receptors: obstacles or opportunities for drug discovery?Caroline A Anderson, Roberto Solari, James E Pease
Expert Opinion on Drug Discovery|March 26, 2019
Are academic drug discovery efforts receiving more recognition with declining industry efficiency?Justin S Bryans, Catherine A Kettleborough, Roberto Solari
Current Opinion in Chemical Biology|May 29, 2013
Correctors of the basic trafficking defect of the mutant F508del-CFTR that causes cystic fibrosisVéronique Birault, Roberto Solari, John Hanrahan, et al.
Expert Opinion on Drug Discovery|March 20, 2013
Academia-industry partnerships in drug discoveryMichael Dalrymple, Debbie Taylor, Catherine Kettleborough, et al.
Pageof 4